These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 1583321)

  • 1. Safety and immunogenicity of different immunization regimens of CVD 103-HgR live oral cholera vaccine in soldiers and civilians in Thailand.
    Su-Arehawaratana P; Singharaj P; Taylor DN; Hoge C; Trofa A; Kuvanont K; Migasena S; Pitisuttitham P; Lim YL; Losonsky G
    J Infect Dis; 1992 Jun; 165(6):1042-8. PubMed ID: 1583321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and Immunogenicity of Live Oral Cholera Vaccine CVD 103-HgR in Children and Adolescents Aged 6-17 Years.
    McCarty JM; Gierman EC; Bedell L; Lock MD; Bennett S
    Am J Trop Med Hyg; 2020 Jan; 102(1):48-57. PubMed ID: 31769402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An Open Label Non-inferiority Trial Assessing Vibriocidal Response of a Killed Bivalent Oral Cholera Vaccine Regimen following a Five Year Interval in Kolkata, India.
    Kanungo S; Desai SN; Saha J; Nandy RK; Sinha A; Kim DR; Bannerjee B; Manna B; Yang JS; Ali M; Sur D; Wierzba TF
    PLoS Negl Trop Dis; 2015 May; 9(5):e0003809. PubMed ID: 26023778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody-Based Correlates of Protection Against Cholera Analysis of a Challenge Study in a Cholera-Naïve Population.
    Haney DJ; Lock MD; Simon JK; Harris J; Gurwith M
    Clin Vaccine Immunol; 2017 May; 24(8):. PubMed ID: 28566334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seroconversion and Kinetics of Vibriocidal Antibodies during the First 90 Days of Re-Vaccination with Oral Cholera Vaccine in an Endemic Population.
    Chisenga CC; Phiri B; Ng'ombe H; Muchimba M; Musukuma-Chifulo K; Silwamba S; Laban NM; Luchen C; Liswaniso F; Chibesa K; Mubanga C; Mwape K; Simuyandi M; Cunningham AF; Sack D; Bosomprah S
    Vaccines (Basel); 2024 Apr; 12(4):. PubMed ID: 38675772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Historical Review of Military Medical Strategies for Fighting Infectious Diseases: From Battlefields to Global Health.
    Biselli R; Nisini R; Lista F; Autore A; Lastilla M; De Lorenzo G; Peragallo MS; Stroffolini T; D'Amelio R
    Biomedicines; 2022 Aug; 10(8):. PubMed ID: 36009598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longitudinal analysis of human humoral responses after vaccination with a live attenuated V. cholerae vaccine.
    Adekunle O; Dretler A; Kauffman RC; Cho A; Rouphael N; Wrammert J
    PLoS Negl Trop Dis; 2021 Sep; 15(9):e0009743. PubMed ID: 34478460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An overview of Vaxchora
    Saluja T; Mogasale VV; Excler JL; Kim JH; Mogasale V
    Hum Vaccin Immunother; 2020; 16(1):42-50. PubMed ID: 31339792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rotavirus vaccines: why continued investment in research is necessary.
    Arnold MM
    Curr Clin Microbiol Rep; 2018 Mar; 5(1):73-81. PubMed ID: 29805958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Causes of impaired oral vaccine efficacy in developing countries.
    Parker EP; Ramani S; Lopman BA; Church JA; Iturriza-Gómara M; Prendergast AJ; Grassly NC
    Future Microbiol; 2018 Jan; 13(1):97-118. PubMed ID: 29218997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized, Placebo-Controlled, Double-Blind Phase 2 Trial Comparing the Reactogenicity and Immunogenicity of a Single Standard Dose to Those of a High Dose of CVD 103-HgR Live Attenuated Oral Cholera Vaccine, with Shanchol Inactivated Oral Vaccine as an Open-Label Immunologic Comparator.
    Sow SO; Tapia MD; Chen WH; Haidara FC; Kotloff KL; Pasetti MF; Blackwelder WC; Traoré A; Tamboura B; Doumbia M; Diallo F; Coulibaly F; Onwuchekwa U; Kodio M; Tennant SM; Reymann M; Lam DF; Gurwith M; Lock M; Yonker T; Smith J; Simon JK; Levine MM
    Clin Vaccine Immunol; 2017 Dec; 24(12):. PubMed ID: 29021299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of enteric infections on response to oral poliovirus vaccine: a systematic review and meta-analysis.
    Parker EP; Kampmann B; Kang G; Grassly NC
    J Infect Dis; 2014 Sep; 210(6):853-64. PubMed ID: 24688069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age-dependent association among Helicobacter pylori infection, serum pepsinogen levels and immune response of children to live oral cholera vaccine CVD 103-HgR.
    Muhsen K; Lagos R; Reymann MK; Graham DY; Pasetti MF; Levine MM
    PLoS One; 2014; 9(1):e83999. PubMed ID: 24454714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and immunogenicity of single-dose live oral cholera vaccine strain CVD 103-HgR, prepared from new master and working cell banks.
    Chen WH; Greenberg RN; Pasetti MF; Livio S; Lock M; Gurwith M; Levine MM
    Clin Vaccine Immunol; 2014 Jan; 21(1):66-73. PubMed ID: 24173028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progress and pitfalls in Shigella vaccine research.
    Barry EM; Pasetti MF; Sztein MB; Fasano A; Kotloff KL; Levine MM
    Nat Rev Gastroenterol Hepatol; 2013 Apr; 10(4):245-55. PubMed ID: 23419287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune responses to cholera in children.
    Leung DT; Chowdhury F; Calderwood SB; Qadri F; Ryan ET
    Expert Rev Anti Infect Ther; 2012 Apr; 10(4):435-44. PubMed ID: 22512753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New-generation vaccines against cholera.
    Clemens J; Shin S; Sur D; Nair GB; Holmgren J
    Nat Rev Gastroenterol Hepatol; 2011 Nov; 8(12):701-10. PubMed ID: 22064524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of early life exposures to geohelminth infections on the development of vaccine immunity, allergic sensitization, and allergic inflammatory diseases in children living in tropical Ecuador: the ECUAVIDA birth cohort study.
    Cooper PJ; Chico ME; Guadalupe I; Sandoval CA; Mitre E; Platts-Mills TA; Barreto ML; Rodrigues LC; Strachan DP; Griffin GE
    BMC Infect Dis; 2011 Jun; 11():184. PubMed ID: 21714922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral vaccines for preventing cholera.
    Sinclair D; Abba K; Zaman K; Qadri F; Graves PM
    Cochrane Database Syst Rev; 2011 Mar; 2011(3):CD008603. PubMed ID: 21412922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunology of gut mucosal vaccines.
    Pasetti MF; Simon JK; Sztein MB; Levine MM
    Immunol Rev; 2011 Jan; 239(1):125-48. PubMed ID: 21198669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.